Achievements

Thumbnail image for LSD Revealed: A Celebration of Beckley/Imperial Research

LSD Revealed: A Celebration of Beckley/Imperial Research

April 14, 2016 Achievements

On Wednesday 13 April, Amanda Feilding and David Nutt hosted a symposium in the Wellcome Trust Lecture Hall at the Royal Society, the UK National Academy of Science. The occasion was a celebration of the findings which have emerged from the latest investigation into LSD by the Beckley/Imperial Research programme, of which they are the […]

Continue Reading →
Thumbnail image for LSD Revealed: Scientific Papers from the Beckley/Imperial Research Programme

LSD Revealed: Scientific Papers from the Beckley/Imperial Research Programme

April 12, 2016 Achievements

Our symposium at the Royal Society on Wednesday 13 April is a celebration of the accomplishments of the Beckley/Imperial Research Programme and commemoration of the release of the results from first ever brain imaging study on LSD. Our main findings have been published this week in the Proceedings of the National Academy of Sciences: “Neural […]

Continue Reading →
Thumbnail image for LSD Revealed: the World’s First Images of the Brain on LSD

LSD Revealed: the World’s First Images of the Brain on LSD

April 12, 2016 Achievements

The Beckley/Imperial Research Programme has released the world’s first images of the human brain on LSD. The images are part of the first ever brain imaging study to examine the effects of LSD on the human brain; the findings have been published this week in the Proceedings of the National Academy of Sciences: “Neural Correlates […]

Continue Reading →
Thumbnail image for The Visual Effects of Ayahuasca in Humans: The First Study to Employ a Ketanserin Blockade

The Visual Effects of Ayahuasca in Humans: The First Study to Employ a Ketanserin Blockade

March 30, 2016 Achievements

Ayahuasca, like other major psychedelic drugs, is thought to produce its characteristic effects through interaction with 5-HT2A receptors. But what happens if we block the receptor with ketanserin, a drug that selectively binds to the 5-HT2A receptors? This is the world’s first study to test if the main psychological and physiological effects of ayahuasca still […]

Continue Reading →
Thumbnail image for A Review on Ayahuasca: Pharmacology, Neuroscience and Therapeutic Potential

A Review on Ayahuasca: Pharmacology, Neuroscience and Therapeutic Potential

March 17, 2016 Achievements

Amanda Feilding has contributed to review of current knowledge relating to ayahuasca, co-authored by Elisabet Domínguez-Clavé, Joaquim Soler, Matilde Elices, Juan C. Pascual, Enrique Álvarez, Mario de la Fuente Revenga, Pablo Friedlander and Jordi Riba. The paper evaluates the recent scientific evidence for the therapeutic potential of ayahuasca, including its potential to treat various psychiatric […]

Continue Reading →
Thumbnail image for At last, the edifice of drugs prohibition is starting to crumble

At last, the edifice of drugs prohibition is starting to crumble

June 18, 2013 Achievements

We are seeing a dramatic shift in favour of drug decriminalisation and unlocking the therapeutic potential of psychedelics Amanda Feilding guardian.co.uk, The past two months have been an incredibly busy and productive time for global drug policy reform and scientific research into psychedelic drugs. Never in my 15 years as director of the Beckley Foundation

Continue Reading →

Exciting new findings produced through the Beckley-Imperial College Psychedelic Research Programme

February 2, 2012 Achievements

Published in the British Journal of Psychiatry Implications for psychedelic-assisted psychotherapy: a functional magnetic resonance imaging study with psilocybin, February 2012 Background Psilocybin is a classic psychedelic drug that has a history of use in psychotherapy. One of the rationales for its use was that it aids emotional insight by lowering psychological defences. Aims To […]

Continue Reading →

New Draft Framework Convention on Cannabis Control

December 10, 2010 Achievements

Background Cannabis is subject to international control by the 1961 Single Convention on Narcotic Drugs, as amended in 1972 (http://www.incb.org/incb/convention_1961.html), and it is also affected by the 1988 Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances (http://www.incb.org/incb/convention_1988.html).  Because a basic principle of these conventions is that legitimate use of substances covered by them […]

Continue Reading →

International Society for the Study of Drug Policy

October 7, 2010 Achievements

The ISSDP was initiated at the Beckley Foundation Global Drug Policy Seminar 2004. Currently the ISSDP Coordinating Committee is chaired by Professor Peter Reuter of the University of Maryland, USA . Its Vice-President is Alison Ritter, Associate Professor at the National Drug and Alcohol Research Centre, Australia. The other Committee members are: Henri Bergeron (Senior […]

Continue Reading →

The First UK-based Scientific Study on the Effects of Psilocybin

October 7, 2010 Achievements

For many years the Beckley Foundation has been working at opening up psychedelic research in the UK. Finally Amanda Feilding has been successful initiating and collaborating on a project that is currently being managed by Dr Robin Carhart-Harris under the supervision of Professor David Nutt, Head of Neuropsychopharmacology at Imperial College London, and Chair of […]

Continue Reading →

ACHIEVEMENTS IN SCIENTIFIC RESEARCH

September 14, 2010 Achievements

Studies initiated and supported by the Beckley Foundation include: The first LSD research on humans for more than thirty years. The first fMRI study of the effect of a hallucinogen on brain function. Investigations into the medicinal and therapeutic uses of illegal drugs. Comparison of the health risks of legal drugs (alcohol and nicotine) versus […]

Continue Reading →

ACHIEVEMENTS IN POLICY

September 14, 2010 Achievements

ACHIEVEMENTS IN POLICY Achievements of the Beckley Foundation in the field of Drug Policy include: Beckley Foundation Seminars: These highly influential seminars have been instrumental in persuading policy-makers and opinion-formers to accept the need for drugs policy reform. Scale of Harm: Beckley introduced the principal of the Scale of Harm – a scientifically-based measure of the relative […]

Continue Reading →

A Rational Scale of Harm

September 9, 2010 Achievements

Development of a Rational Scale to Assess the Harm of Drugs of Potential Misuse Article in the Lancet 2007: 369, 1047-1053 (Full Text) One of the recurring themes of the Beckley Foundation seminars over the last few years has been highlighting the haphazard and inflexible nature of the current classification system for illegal drugs, which […]

Continue Reading →

The Beckley Foundation’s Global Cannabis Commission new Book ‘Cannabis Policy: Moving Beyond Stalemate’

September 2, 2010 Achievements

The Beckley Foundation’s Global Cannabis Commission is now published as a book in association with Oxford University Press entitled: ‘Cannabis Policy: Moving Beyond Stalemate’ Cannabis, marijuana, pot, ganja – it goes by many names – is by far the most widely used illegal substance, and accounts for more arrests than any other drug. Politicians the […]

Continue Reading →